Found 28 matching trials
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma PHASE1 This was a first-in-human study to evaluate the feasibility, safety and pre...
Show More Location
Uni of Chi Medi Ctr Hema and Onco
Learn More & Join Trial
BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma EARLY_PHASE1 The goal of this clinical trial is to study the feasibility and efficacy of...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma PHASE1 Background:
\- T cells are white blood cells that fight several cancers. O...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy PHASE1 This is an investigator-initiated, single-center, open-label study of C-CAR...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of the study is to characterize safety of JNJ-68284528 and esta...
Show More Location
Mayo Clinic Cancer Center-Scottsdale
Learn More & Join Trial
Plan Development for Giving Teclistamab in the Outpatient Setting PHASE4 This is a pilot study to develop an outpatient-based process for the admini...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma PHASE1 Background:
Multiple myeloma is a cancer of the blood plasma cells. It usu...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of this study is to assess the safety, tolerability, preliminar...
Show More Learn More & Join Trial
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy PHASE1 This is an investigator-initiated, single-center, open-label study of C-CAR...
Show More Location
The Affiliated Hospital of Qingdao University
Learn More & Join Trial